Is BPC-157 banned in sport? WADA's prohibited list, explained
Prepared by: Research Desk
Prepared by: Research Desk. Sources are linked for verification.
The short answer is yes. Under the World Anti-Doping Agency (WADA) framework, BPC-157 falls within the category of non-approved substances, which the Prohibited List bans at all times, in and out of competition [1]. A 2025 systematic review in orthopaedic sports medicine reaches the same conclusion from the other direction. It describes BPC-157 as lacking FDA approval and as banned in professional sports, while noting growing interest in it within sports-medicine settings [2].
That answer raises further questions. Which part of the list covers it? Why is a substance with no approved medical use banned at all? And can laboratories actually find it in a sample? This explainer takes each in turn, using only published records. For the wider legal picture (FDA status, compounding and possession), see our separate file, Is BPC-157 legal?.
Where BPC-157 sits on the Prohibited List
WADA publishes the Prohibited List as the reference document for which substances and methods are banned under the World Anti-Doping Code [1]. It is organised into numbered sections. Some apply only in competition. Others apply at all times.
The first section, S0 (Non-Approved Substances), covers any pharmacological substance not addressed by another section of the list and with no current approval by any government regulatory health authority for human therapeutic use [1]. In practice, it is a catch-all. It exists so that experimental compounds, drugs abandoned during development and substances sold outside regulated channels cannot slip through simply because they are not named elsewhere.
BPC-157 fits that description. It is named as an example within S0 in recent editions of the list [1]. Because S0 substances are prohibited at all times, the ban is not limited to race day or match day. It also covers out-of-competition testing [1].
Two points about reading the list accurately:
Named examples are not the whole category. S0 applies to any substance meeting its definition, whether or not it is listed by name. Naming BPC-157 removes any argument about whether it qualifies.
The list is reissued every year. WADA updates it annually, so any statement about status should be tied to a specific edition. The statements on this page reflect the list as published on WADA's site at the time of writing [1].
Why a non-approved substance is banned
It can seem odd that sport bans a compound that no regulator has approved. The logic of S0 is precautionary. A substance without regulatory approval has not been through the trials a regulator would require, so its effects in people and its safety profile are largely undocumented. The anti-doping system regards that uncertainty as grounds for prohibition rather than tolerance [1].
The U.S. regulatory record for BPC-157 reflects the same gap. The FDA includes BPC-157 on its list of bulk drug substances for compounding that may present significant safety risks. Its entry notes possible immunogenicity concerns for certain routes of administration and the limited safety information available [3]. The FDA's Pharmacy Compounding Advisory Committee also met on 23–24 July 2026 [4]. Our legal-status file sets out how BPC-157 features in that record and what has and has not changed.
On the research side, the human evidence remains thin. A 2026 systematic review assessed human evidence for BPC-157 in orthopaedic and regenerative medicine, covering both efficacy and safety [5]. Our evidence guide summarises that literature as a small number of uncontrolled reports set against a much larger body of animal work. For an S0 assessment, the key fact is simpler. No government regulator has approved BPC-157 for human therapeutic use.
Can anti-doping labs detect it?
A ban only works if it can be enforced. Detection science for BPC-157 has a published history going back almost a decade.
Confiscated material, 2017. Cox and colleagues published work on the detection and in vitro metabolism of BPC-157 and another peptide, MGF R23H, both described in the title as confiscated [6]. The study type is laboratory analysis, not a human study. Its significance for sport is that it shows anti-doping science was examining BPC-157 as material actually turning up in seized products, and working out how it breaks down. Knowing the breakdown products matters because a lab may need to look for metabolites as well as the original molecule.
Metabolic profiling, 2023. Tian and colleagues described BPC-157 in their title as a "novel doping" agent. They reported a stable isotope labelling, nontargeted strategy for characterising its in vitro metabolic profile using UHPLC-HRMS, a high-resolution mass spectrometry technique [7]. Again, this is an in vitro laboratory study. It extends the 2017 work by mapping metabolites more systematically, which is the groundwork for reliable screening.
The wider toolkit. A 2016 review of methods for doping detection outlines the analytical approaches labs rely on, including chromatography coupled with mass spectrometry [8]. A 2026 paper by Mazzarino and colleagues reported a rapid, harmonised analytical workflow for peptidic and non-peptidic doping agents in both dried and liquid blood samples [9]. That paper concerns the broader class of peptide-type doping agents rather than BPC-157 alone. It shows the direction of travel: labs are building methods that can screen many small peptide substances at once and work with dried blood spots, which are easier to collect and store.
Taken together, these studies show that anti-doping researchers regard BPC-157 as a real-world doping concern, not a theoretical one, and that detection methods have been developed and refined over time [6][7][9].
What the records do not tell us
A skeptical reading should note the limits of what is documented here.
Detection windows. The cited studies are in vitro. They describe metabolism and analytical methods, but they do not establish how long BPC-157 or its metabolites remain detectable in a person [6][7].
Case counts. None of the sources on this page give a tally of anti-doping rule violations involving BPC-157. We do not cite numbers we cannot source.
Product contents. The 2017 study analysed confiscated material [6], but a single analytical study does not tell us what unregulated products generally contain.
How BPC-157 compares with other listed substances
S0 is unusual because it bans by status rather than by effect. Most sections of the list target a pharmacological class, such as anabolic agents or peptide hormones and growth factors, regardless of approval [1]. A substance can be approved medicine and still be prohibited in sport under one of those classes. BPC-157 is the opposite case: it is prohibited partly because it is not approved. If a regulator ever approved it for human use, its listing would need to be reassessed under the other sections, which is one reason status checks should always reference the current edition [1].
Further reading
Anti-doping rules, laboratory science and sport physiology change year to year, and a good reference book is one of the most efficient ways to build a working understanding of how the system fits together. Before choosing one, a few neutral criteria separate a useful title from an outdated one.
Edition date. The list is reissued annually, so a book printed several years ago may describe rules that have since changed. Prefer recent editions and check the publication year against the current list.
Author background. Look for authors with published work in sports science, analytical chemistry or sports law, and for books that cite their sources so claims can be traced.
Scope. Some titles focus on rules and governance; others on testing methods or exercise physiology. Choose the one that matches the question being researched.
Format and price. Print, ebook and audio editions often differ in price, and ebooks are sometimes updated more quickly. Compare formats before buying.
Our selection criteria for any book listed here are the same as above, and no publisher or retailer influences what we write. Full details of how this site is funded are on our About page.
Textbooks and edited volumes with reference lists are generally more durable than popular titles, because the underlying science they summarise can be checked against the original papers.
Frequently asked questions
Is BPC-157 banned only during competition?
No. It falls within S0, the non-approved substances category, which WADA prohibits at all times, both in and out of competition [1]. That means out-of-competition testing can also cover it.
Why is BPC-157 listed if it has no approved medical use?
S0 exists to capture substances that no government regulatory health authority has approved for human therapeutic use [1]. BPC-157 lacks FDA approval [2], and the FDA has recorded safety concerns about it in compounding [3]. That status is what places it in S0.
Have labs developed tests for BPC-157?
Published laboratory studies have described its detection and in vitro metabolism, including work on confiscated material in 2017 and metabolic profiling by high-resolution mass spectrometry in 2023 [6][7]. Broader workflows for peptide-type doping agents in blood samples continue to be developed [9].
Last updated: 19 October 2026.
Related on this site
How to evaluate a BPC-157 study: a reader's checklist and reading list
Sports wearables buyer's guide: GPS watches, chest straps, trackers
BPC-157 vs TB-500: the evidence and regulatory records compared
BPC-157 history: where the gastric peptide research came from
BPC-157 animal studies: what rodent models can and cannot show
Not medical advice. This page reports published research and regulatory records for information only.
Research-only notice: Content on this site is provided for research and educational purposes only and is not intended for human use. It is not medical advice.
Translation notice: Some content on this site may have been machine-translated using Google Translate and may contain errors.
Sources
Read next
How to evaluate a BPC-157 study: a reader's checklist and reading list
A five-question checklist for reading BPC-157 studies, applied to the three human reports and two systematic reviews, plus a labelled reading list on evidence appraisal.
Sports wearables buyer's guide: GPS watches, chest straps, trackers
How to compare wearables for athletes: what GPS watches, chest straps and activity trackers measure, which figures are estimates, and how to weigh battery, data export, privacy and price.
BPC-157 vs TB-500: the evidence and regulatory records compared
Two peptides, one thin record. How BPC-157 and TB-500 compare on human evidence, FDA's July 2026 compounding review and WADA's Prohibited List, with every unverified claim flagged.